Author: Yang, Yuan; Li, Wen; Zhang, Qinge; Zhang, Ling; Cheung, Teris; Ng, Chee H; Xiang, Yu-Tao
Title: Should people with severe mental illness be prioritized for the COVID-19 vaccination? Cord-id: 8ybqk8f1 Document date: 2021_4_10
ID: 8ybqk8f1
Snippet: The coronavirus disease-19 (COVID-19) has spread throughout the world, affecting many vulnerable populations including patients with severe mental illness (SMI). Recent studies have found that patients with SMI compared to the general population could have a greater risk of morbidity and mortality from COVID-19 due to cognitive impairment, poor awareness of risk, and difficulties in complying with infection control measures. Although some researchers have suggested that patients with SMI should
Document: The coronavirus disease-19 (COVID-19) has spread throughout the world, affecting many vulnerable populations including patients with severe mental illness (SMI). Recent studies have found that patients with SMI compared to the general population could have a greater risk of morbidity and mortality from COVID-19 due to cognitive impairment, poor awareness of risk, and difficulties in complying with infection control measures. Although some researchers have suggested that patients with SMI should be prioritized for COVID-19 vaccination to reduce the risk of infection, this issue remains controversial.
Search related documents:
Co phrase search for related documents- acceptance rate and low efficacy: 1
- acid vaccine and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- acute respiratory and additional risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acute respiratory and adenovirus vector vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute respiratory and long term effect: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute respiratory and long term efficacy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acute respiratory and low efficacy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
- additional risk and low efficacy: 1
- adenovirus vector vaccine and long term efficacy: 1
- long term effect and low efficacy: 1
- long term efficacy and low efficacy: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date